COI
BMY icon

Capital One Investing’s Bristol-Myers Squibb BMY Stock Holding History

Capital One Investing’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$819K Buy
16,201
+1,100
+7% +$51.7K 0.19% 87
2019
Q2 		$685K Buy
15,101
+7,832
+108% +$365K 0.17% 95
2019
Q1 		$347K Buy
+7,269
New +$362K 0.09% 138

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital One Investing's BMY Position: Q3 2019 in Review

Capital One Investing increased its Bristol-Myers Squibb (BMY) stake by 7.3% in Q3 2019, buying an estimated $51.7K and bringing the position to 16,201 shares worth $819K. The position accounts for 0.19% of the portfolio, ranked #87.

Capital One Investing first reported a position in BMY in Q1 2019 and has held it in 3 quarters since. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Capital One Investing held 16,201 shares of Bristol-Myers Squibb worth $819K as of Q3 2019.
  • Capital One Investing bought 1,100 Bristol-Myers Squibb shares in Q3 2019, an estimated $51.7K.
  • Bristol-Myers Squibb made up 0.19% of Capital One Investing's portfolio in Q3 2019, its #87 holding.
  • Capital One Investing first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 3 quarters since.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Capital One Investing's 13F filing for Q3 2019, filed 14 Nov 2019.